Investors
Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
Key information
Annual Report 2020
We published our Annual Report 2020 on 09 March 2021. View the summary and download the full report or individual sections.
Latest information
Latest press releases
- GSK announces Dr Anne Beal to join the Board as Non-Executive Director
- GSK to support manufacture of Novavax’ COVID-19 vaccine
- Lilly, Vir Biotechnology and GSK announce positive topline data from the phase 2 BLAZE-4 trial evaluating bamlanivimab with VIR-7831 in low-risk adults with COVID-19
2020 Full year and fourth quarter results announcement
We announced our full year and fourth quarter results for the period ended 31 December 2020 on Wednesday 3 February 2021.
Sign up for announcements
Sign up to receive email notifications when we publish a stock exchange announcement.